Skip to main content

Find Clinical Trials

Home
Conditions
Renal Cell Carcinoma (RCC)

Clinical trial condition

Renal Cell Carcinoma (RCC)

Explore clinical trials studying Renal Cell Carcinoma (RCC). Study availability and eligibility vary by location and protocol.

53 public trials 22 recruiting studies

Refine in advanced search Browse all conditions

Renal Cell Carcinoma (RCC) trial results

Active, Not Recruiting

A Study Based on CT Radiomics for Distinguishing Benign From Malignant Renal Tumors and Assessing Their Aggressiveness.

NCT07060248

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Second Xiangya Hospital Changsha, Hunan, China

View Trial Details

Active, Not Recruiting

Vorolanib Monotherapy or in Combination With Toripalimab as Adjuvant Therapy for Patients With Intermediate-high Risk of Recurrence in Renal Cell Carcinoma

NCT07047001

Conditions: Adenocarcinoma, Adjuvant, Carcinoma, +15 more
Locations: Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)

NCT03634540

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +26 more
Locations: USC Norris Comprehensive Cancer Center ( Site 0060) Los Angeles, California, United States

Cedars Sinai Medical Center Samuel Oschin Comp. Cancer Institute ( Site 0003) Los Angeles, California, United States

Sylvester Comprehensive Cancer Center ( Site 0023) Miami, Florida, United States

Dana Farber Cancer Center ( Site 0006) Boston, Massachusetts, United States

View Trial Details